CRNX
Crinetics Pharmaceuticals Inc
Price:
31.24
USD
Volume:
530,635
United States | Biotechnology
CRNX Gross Margin
As of 2025-05-18, the Gross Margin of Crinetics Pharmaceuticals Inc (CRNX) is 7775.2%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
CRNX Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 7775.2% |
| 2023-12-31 | - |
| 2022-12-31 | - |
| 2021-12-31 | - |
| 2020-12-31 | - |
| 2019-12-31 | - |
| 2018-12-31 | - |
| 2017-12-31 | - |
| 2016-12-31 | - |
| - |
CRNX Gross Margin - Peers Comparison